Cost-utility Analysis of Second-generation Direct-acting Antivirals for Hepatitis C | Hepatitis Monthly | Full Text
Treatment groups by regimen. SOF, sofosbuvir; LDV, ledipasvir; SIM,... | Download Scientific Diagram
Pooling SAE rates of SOFL/LDV regimen on HCV genotype 6. SAE, serious... | Download Scientific Diagram
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study | BMJ Open
Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b - Zakalashvili - 2021 - Hepatology Research - Wiley Online Library
ION-1 Design LDV/SOF LDV/SOF + RBV Randomisation* 1 : 1 : 1 : 1 Open-label ION-1 Study: LDV/SOF + RBV for genotype 1 W24W12 ≥ 18 years Chronic HCV infection. - ppt download
Respuestas para un nuevo abordaje de la hepatitis C
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
ION-3 Study: LDV/SOF + RBV for naïve genotype 1 - ppt download
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Incremental cost and effectiveness of SOF/LDV and SOF/VEL relative to... | Download Scientific Diagram
HepDart) Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Genotype 1 (GT1) Treatment-Naïve (TN) Non-Cirrhotic (NC) Patients with HCV Viral load (VL) <6 million IU/ml (6M); A Comparative Analysis of the Phase-3 ION-3 Efficacy
Simulation plot predicting the probability of LDV-resistant mutant... | Download Scientific Diagram
Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China
Efficacy and tolerability of interferon‑free regimen for patients with genotype‑1 HCV infection
EVALUACIÓN DE LA EFICACIA DE NUEVOS ANTIVÍRICOS DE ACCIÓN DIRECTA EN COMBINACIÓN CON SOFOSBUVIR FRENTE A GENOTIPO 1 DE VHC
Six weeks of sofosbuvir/ledipasvir (SOF/LDV) are sufficient to treat acute hepatitis C virus genotype 1 monoinfection: The HepNet Acute HCV IV Study
Informe de Posicionamiento Terapéutico de ledipasvir/sofosbuvir (Harvoni®)
Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C | Anales de Pediatría
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
RASs found pre- and post-treatment with LDV/SOF + RBV detected as low... | Download Scientific Diagram
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis - ScienceDirect
Figure 4, Illustration of the Sensitivity of LDV/SOF Sustained Virologic Response to One (LDV/SOF 22/1) and Two (LDV/SOV 22/2) Additional Data Points - Ledipasvir/Sofosbuvir (Harvoni) - NCBI Bookshelf
EVALUACION DE LA EFICACIA Y SEGURIDAD DE LOS TRATAMIENTOS CON LOS NUEVOS ANTIVIRALES DIRECTOS DEL VHC EN PACIENTES COINFECTADOS
HCV-Trials.com : A regularly updated website with all most recent clinical trials data in HCV infection
